Zobrazeno 1 - 10
of 37
pro vyhledávání: '"A. A. Rukavitsin"'
Autor:
A. A. Mamedova, N. E. Mochkin, V. O. Sarzhevskiy, E. A. Demina, V. S. Bogatyrev, A. A. Spornik, A. A. Samoylova, A. A. Rukavitsin, E. G. Smirnova, A. E. Bannikova, V. Ya. Melnichenko, N. B. Mikhaylova, E. S. Borzenkova, L. V. Stelmakh, Yu. R. Zalyalov, A. A. Semenova, G. S. Tumyan, M. A. Danilova, O. A. Konova, N. A. Falaleeva, A. Yu. Terekhova, M. A. Vernyuk, A. M. Chervontseva, L. S. Khayrullina, A. A. Maslov, I. B. Lysenko, Yu. A. Alekseeva, E. S. Pavlyuchenko, A. A. Mirsaitov, A. A. Zverkova, I. V. Ishmatova, S. A. Volchenkov, M. S. Motalkina, I. S. Zyuzgin
Publikováno v:
Онкогематология, Vol 17, Iss 3, Pp 40-47 (2022)
Aim. To study the efficacy and safety of combined immunochemotherapy according to the DHAp protocol + nivolumab in patients with refractory/relapsed classical Hodgkin's lymphoma before autologous hematopoietic stem cell transplantation.Materials and
Externí odkaz:
https://doaj.org/article/61dd8e7c89fc477eb1ba03f4c408b04b
Autor:
Vladislav O. Sarzhevskiy, Vladimir Ia. Melnichenko, Irina V. Panshina, Nikita E. Mochkin, Vladimir S. Bogatyrov, Maria M. Borshevetskaya, Elena G. Smirnova, Anna E. Bannikova, Anastasia A. Samoylova, Aysel A. Mamedova, Anatolij A. Rukavitsin, Sergei S. Vasilev, Oleg Iu. Bronov
Publikováno v:
Современная онкология, Vol 23, Iss 3, Pp 496-500 (2021)
When evaluating the effect of therapy for malignant neoplasms with inhibitors of CTLA-4, PD-1 and PD-L1, the phenomenon of pseudoprogression may occur. Pseudoprogression is an increase in the volume of tumor tissue due to immunocompetent cells (lymph
Externí odkaz:
https://doaj.org/article/087c99ed4f454995bde9965434ae6e7f
Autor:
Victoria V Tutaeva, Maria R Ovsiannikova, Alexander N Bobin, Alexey V Gorbunov, Sergey I Kurbanov, Oleg A Rukavitsin
Publikováno v:
Oxford Medical Case Reports. 2023
We describe in detail a case of the anaplastic large cell lymphoma (ALCL) type of primary bone lymphoma, which initially was diagnosed and treated as osteomyelitis. The diagnosis was delayed because of unspecific clinical symptoms and uncertain radio
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0b45a902775eeae1c2aaf5fd0d50ad83
https://doi.org/10.1093/omcr/omad025
https://doi.org/10.1093/omcr/omad025
Autor:
Victoria Vladimirovna Tutaeva, Maria Romanovna Ovsannikova, Alexander Nikolaevich Bobin, Yurii Miroslavovich Kuchma, Oleg Anatolievich Rukavitsin
Publikováno v:
Oxford Medical Case Reports. 2022
Richter’s syndrome (RS) is the next step in the progression of chronic lymphocytic leukemia (CLL) progression. It leads to reduced overall patient survival, the necessity of aggressive chemotherapy and a decline in the quality of life. The first li
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7b92d4d339dd15183d2654fdc84f660e
https://doi.org/10.1093/omcr/omac111
https://doi.org/10.1093/omcr/omac111
Autor:
S. Kazakov, O. Rukavitsin
Publikováno v:
Clinica Chimica Acta. 530:S192
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ea7c9fe48a9be1b0e3bc241534121f12
https://doi.org/10.1016/j.cca.2022.04.517
https://doi.org/10.1016/j.cca.2022.04.517
Autor:
Tutaeva, Victoria V, Ovsiannikova, Maria R, Bobin, Alexander N, Gorbunov, Alexey V, Kurbanov, Sergey I, Rukavitsin, Oleg A
Publikováno v:
Oxford Medical Case Reports; Mar2023, Vol. 2023 Issue 3, p1-3, 3p
Publikováno v:
Onkogematologiâ, Vol 13, Iss 1, Pp 45-53 (2018)
The review contains data on new important aspects of the pathogenesis and treatment of anemia of chronic diseases. The complex multicomponent genesis of this anemia is shown, which is based on the disturbances in iron metabolism, damage of proliferat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cb6e7e6c636bee6c848f2cce0126c8ec
https://oncohematology.abvpress.ru/ongm/article/view/275
https://oncohematology.abvpress.ru/ongm/article/view/275
Autor:
Tutaeva, Victoria Vladimirovna, Ovsannikova, Maria Romanovna, Bobin, Alexander Nikolaevich, Kuchma, Yurii Miroslavovich, Rukavitsin, Oleg Anatolievich
Publikováno v:
Oxford Medical Case Reports; Oct2022, Vol. 2022 Issue 10, p1-3, 3p
Publikováno v:
Актуальные направления научных исследований XXI века: теория и практика. 2:318-323
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f0ce420476a60b5d9ed74024ddbbc2fd
https://doi.org/10.12737/5175
https://doi.org/10.12737/5175
Autor:
Todd M. Zimmerman, Ka Lung Wu, Helgi van de Velde, Clarissa M. Uhlar, Oleg Rukavitsin, Thomas A. Puchalski, Sheeba K. Thomas, Ming Qi, Lucien Noens, Alexander Suvorov, Joseph W. Fay, Olga S. Samoylova, Rajesh Bandekar
Publikováno v:
Cancer Chemotherapy and Pharmacology. 73:35-42
A phase 1 study evaluated the QTc prolongation potential of siltuximab, a chimeric, anti-interleukin-6 mAb, in patients with monoclonal gammopathy of undetermined significance (MGUS), smoldering multiple myeloma (SMM), or low-volume MM. Patients with
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::30aef71ec701e814b8d1eb844bc81d26
https://doi.org/10.1007/s00280-013-2314-7
https://doi.org/10.1007/s00280-013-2314-7